Print ISSN: 2393-9079
Online ISSN: 2393-9087
CODEN : IJPPTK
Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...Case Report
Author Details :
Volume : 3, Issue : 4, Year : 2016
Article Page : 225-226
Abstract
Anaphylaxis is a rare condition during ante natal care since most of the drugs except nutraceuticals are avoided in pregnancy unless essentially required to prevent developing foetus from any teratogenic effects. An anaphylactic reaction follows idiosyncrasy that may occur with any drug or food to which an individual is previously known or unknown to be allergic. Antibiotics and NSAIDs are the most common class of drugs known to cause allergic reactions. Maternal anaphylaxis has the potential to cause foetal defects (morbidity) and in rare cases foetal death (mortality), latter possibly due to hypoxia. The authors here report a similar case of maternal anaphylaxis to ciprofloxacin infusion during third trimester in which maternal outcome was positive but 8 months foetus died within an hour of reaction. Iron sucrose infusion was also administered to the mother prior to ciprofloxacin in a community clinic.
Keywords: Ciprofloxacin, Iron sucrose, Anaphylaxis, Foetal Death, Adverse Drug Reaction
How to cite : Goyal C, Rafi M, Khan G, Anaphylaxis to parenteral ciprofloxacin in mother leading to foetal death. Indian J Pharm Pharmacol 2016;3(4):225-226
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.